CDKN2A and melanoma: Data regarding the frequency of germline mutations in the CDKN2A gene for Brazilian individuals fulfilling clinical criteria for familial melanoma are scarce and differ according to the region studied and the adopted criteria, varying from 0% to 14% [21,24,25,26].